Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Soft Tissue Acellular Dermal Matrix (ADM) Market Research Report 2024

Global Soft Tissue Acellular Dermal Matrix (ADM) Market Research Report 2024

Industry: Medical Devices & Consumables

Published Date: 2024-11-15

Pages: 91 Pages

Report ld: 3375511

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Soft Tissue Acellular Dermal Matrix (ADM) Market Size(US$)

CAGR 2024-2030

2.8%

Market Size,2030

USD 105

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 89.2 million

Market Forecast in 2030(Value)

US$ 105 million

CAGR

2.8%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Soft Tissue Acellular Dermal Matrix (ADM) market was valued at US$ 76.8 million in 2023 and is anticipated to reach US$ 105 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.

Soft Tissue Acellular Dermal Matrix (ADM) is a specialized graft material used in various surgical and reconstructive procedures. It is created from donor tissue, usually from human or animal sources, that has been processed to remove all cells, leaving behind a collagen-rich matrix. This acellular matrix acts as a scaffold that supports cell attachment and tissue regeneration, integrating with the patient's own tissue over time.

North American market for Soft Tissue Acellular Dermal Matrix (ADM) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Soft Tissue Acellular Dermal Matrix (ADM) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Soft Tissue Acellular Dermal Matrix (ADM) include Zimmer Biomet, Allergan, Stryker, MTF Biologics, LifeNet Health, Integra LifeSciences, Medtronic, Arthrex, Straumann, Wright Medical Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Soft Tissue Acellular Dermal Matrix (ADM), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Soft Tissue Acellular Dermal Matrix (ADM).

The Soft Tissue Acellular Dermal Matrix (ADM) market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Soft Tissue Acellular Dermal Matrix (ADM) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Soft Tissue Acellular Dermal Matrix (ADM) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Zimmer Biomet

Allergan

Stryker

MTF Biologics

LifeNet Health

Integra LifeSciences

Medtronic

Arthrex

Straumann

Wright Medical Group

Hans Biomed

Xtant Medical

Yantai Zhenghai Bio-Tech

Segment by Type

Human Skin

Animal Skin

Segment by Application

Plastic Surgery

Gynecology

Others

Consumption by Region

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East and Africa

Turkey

Saudi Arabia

UAE

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Soft Tissue Acellular Dermal Matrix (ADM) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Soft Tissue Acellular Dermal Matrix (ADM) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Soft Tissue Acellular Dermal Matrix (ADM) Market Overview

1.1 Product Definition

1.2 Soft Tissue Acellular Dermal Matrix (ADM) by Type

1.2.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Market Value Comparison by Type (2024-2030)

1.2.2 Human Skin

1.2.3 Animal Skin

1.3 Soft Tissue Acellular Dermal Matrix (ADM) by Application

1.3.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Market Value by Application (2024-2030)

1.3.2 Plastic Surgery

1.3.3 Gynecology

1.3.4 Others

1.4 Global Soft Tissue Acellular Dermal Matrix (ADM) Market Size Estimates and Forecasts

1.4.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue 2019-2030

1.4.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales 2019-2030

1.4.3 Global Soft Tissue Acellular Dermal Matrix (ADM) Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Soft Tissue Acellular Dermal Matrix (ADM) Market Competition by Manufacturers

2.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Manufacturers (2019-2024)

2.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Soft Tissue Acellular Dermal Matrix (ADM) Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Soft Tissue Acellular Dermal Matrix (ADM), Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Soft Tissue Acellular Dermal Matrix (ADM), Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Soft Tissue Acellular Dermal Matrix (ADM), Product Type & Application

2.7 Global Key Manufacturers of Soft Tissue Acellular Dermal Matrix (ADM), Date of Enter into This Industry

2.8 Global Soft Tissue Acellular Dermal Matrix (ADM) Market Competitive Situation and Trends

2.8.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Soft Tissue Acellular Dermal Matrix (ADM) Players Market Share by Revenue

2.8.3 Global Soft Tissue Acellular Dermal Matrix (ADM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Soft Tissue Acellular Dermal Matrix (ADM) Market Scenario by Region

3.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Region: 2019-2030

3.2.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Region: 2019-2024

3.2.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Region: 2025-2030

3.3 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Region: 2019-2030

3.3.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Region: 2019-2024

3.3.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Region: 2025-2030

3.4 North America Soft Tissue Acellular Dermal Matrix (ADM) Market Facts & Figures by Country

3.4.1 North America Soft Tissue Acellular Dermal Matrix (ADM) Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Soft Tissue Acellular Dermal Matrix (ADM) Sales by Country (2019-2030)

3.4.3 North America Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Soft Tissue Acellular Dermal Matrix (ADM) Market Facts & Figures by Country

3.5.1 Europe Soft Tissue Acellular Dermal Matrix (ADM) Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Soft Tissue Acellular Dermal Matrix (ADM) Sales by Country (2019-2030)

3.5.3 Europe Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Soft Tissue Acellular Dermal Matrix (ADM) Market Facts & Figures by Region

3.6.1 Asia Pacific Soft Tissue Acellular Dermal Matrix (ADM) Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Soft Tissue Acellular Dermal Matrix (ADM) Sales by Region (2019-2030)

3.6.3 Asia Pacific Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Soft Tissue Acellular Dermal Matrix (ADM) Market Facts & Figures by Country

3.7.1 Latin America Soft Tissue Acellular Dermal Matrix (ADM) Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Soft Tissue Acellular Dermal Matrix (ADM) Sales by Country (2019-2030)

3.7.3 Latin America Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Soft Tissue Acellular Dermal Matrix (ADM) Market Facts & Figures by Country

3.8.1 Middle East and Africa Soft Tissue Acellular Dermal Matrix (ADM) Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Soft Tissue Acellular Dermal Matrix (ADM) Sales by Country (2019-2030)

3.8.3 Middle East and Africa Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Type (2019-2030)

4.1.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Type (2019-2024)

4.1.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Type (2025-2030)

4.1.3 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Type (2019-2030)

4.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Type (2019-2030)

4.2.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Type (2019-2024)

4.2.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Type (2025-2030)

4.2.3 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Type (2019-2030)

4.3 Global Soft Tissue Acellular Dermal Matrix (ADM) Price by Type (2019-2030)

5 Segment by Application

5.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Application (2019-2030)

5.1.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Application (2019-2024)

5.1.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Application (2025-2030)

5.1.3 Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Application (2019-2030)

5.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Application (2019-2030)

5.2.1 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Application (2019-2024)

5.2.2 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Application (2025-2030)

5.2.3 Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Application (2019-2030)

5.3 Global Soft Tissue Acellular Dermal Matrix (ADM) Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Zimmer Biomet

6.1.1 Zimmer Biomet Company Information

6.1.2 Zimmer Biomet Description and Business Overview

6.1.3 Zimmer Biomet Soft Tissue Acellular Dermal Matrix (ADM) Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Zimmer Biomet Soft Tissue Acellular Dermal Matrix (ADM) Product Portfolio

6.1.5 Zimmer Biomet Recent Developments/Updates

6.2 Allergan

6.2.1 Allergan Company Information

6.2.2 Allergan Description and Business Overview

6.2.3 Allergan Soft Tissue Acellular Dermal Matrix (ADM) Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Allergan Soft Tissue Acellular Dermal Matrix (ADM) Product Portfolio

6.2.5 Allergan Recent Developments/Updates

6.3 Stryker

6.3.1 Stryker Company Information

6.3.2 Stryker Description and Business Overview

6.3.3 Stryker Soft Tissue Acellular Dermal Matrix (ADM) Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Stryker Soft Tissue Acellular Dermal Matrix (ADM) Product Portfolio

6.3.5 Stryker Recent Developments/Updates

6.4 MTF Biologics

6.4.1 MTF Biologics Company Information

6.4.2 MTF Biologics Description and Business Overview

6.4.3 MTF Biologics Soft Tissue Acellular Dermal Matrix (ADM) Sales, Revenue and Gross Margin (2019-2024)

6.4.4 MTF Biologics Soft Tissue Acellular Dermal Matrix (ADM) Product Portfolio

6.4.5 MTF Biologics Recent Developments/Updates

6.5 LifeNet Health

6.5.1 LifeNet Health Company Information

6.5.2 LifeNet Health Description and Business Overview

6.5.3 LifeNet Health Soft Tissue Acellular Dermal Matrix (ADM) Sales, Revenue and Gross Margin (2019-2024)

6.5.4 LifeNet Health Soft Tissue Acellular Dermal Matrix (ADM) Product Portfolio

6.5.5 LifeNet Health Recent Developments/Updates

6.6 Integra LifeSciences

6.6.1 Integra LifeSciences Company Information

6.6.2 Integra LifeSciences Description and Business Overview

6.6.3 Integra LifeSciences Soft Tissue Acellular Dermal Matrix (ADM) Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Integra LifeSciences Soft Tissue Acellular Dermal Matrix (ADM) Product Portfolio

6.6.5 Integra LifeSciences Recent Developments/Updates

6.7 Medtronic

6.7.1 Medtronic Company Information

6.7.2 Medtronic Description and Business Overview

6.7.3 Medtronic Soft Tissue Acellular Dermal Matrix (ADM) Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Medtronic Soft Tissue Acellular Dermal Matrix (ADM) Product Portfolio

6.7.5 Medtronic Recent Developments/Updates

6.8 Arthrex

6.8.1 Arthrex Company Information

6.8.2 Arthrex Description and Business Overview

6.8.3 Arthrex Soft Tissue Acellular Dermal Matrix (ADM) Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Arthrex Soft Tissue Acellular Dermal Matrix (ADM) Product Portfolio

6.8.5 Arthrex Recent Developments/Updates

6.9 Straumann

6.9.1 Straumann Company Information

6.9.2 Straumann Description and Business Overview

6.9.3 Straumann Soft Tissue Acellular Dermal Matrix (ADM) Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Straumann Soft Tissue Acellular Dermal Matrix (ADM) Product Portfolio

6.9.5 Straumann Recent Developments/Updates

6.10 Wright Medical Group

6.10.1 Wright Medical Group Company Information

6.10.2 Wright Medical Group Description and Business Overview

6.10.3 Wright Medical Group Soft Tissue Acellular Dermal Matrix (ADM) Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Wright Medical Group Soft Tissue Acellular Dermal Matrix (ADM) Product Portfolio

6.10.5 Wright Medical Group Recent Developments/Updates

6.11 Hans Biomed

6.11.1 Hans Biomed Company Information

6.11.2 Hans Biomed Description and Business Overview

6.11.3 Hans Biomed Soft Tissue Acellular Dermal Matrix (ADM) Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Hans Biomed Soft Tissue Acellular Dermal Matrix (ADM) Product Portfolio

6.11.5 Hans Biomed Recent Developments/Updates

6.12 Xtant Medical

6.12.1 Xtant Medical Company Information

6.12.2 Xtant Medical Description and Business Overview

6.12.3 Xtant Medical Soft Tissue Acellular Dermal Matrix (ADM) Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Xtant Medical Soft Tissue Acellular Dermal Matrix (ADM) Product Portfolio

6.12.5 Xtant Medical Recent Developments/Updates

6.13 Yantai Zhenghai Bio-Tech

6.13.1 Yantai Zhenghai Bio-Tech Company Information

6.13.2 Yantai Zhenghai Bio-Tech Description and Business Overview

6.13.3 Yantai Zhenghai Bio-Tech Soft Tissue Acellular Dermal Matrix (ADM) Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Yantai Zhenghai Bio-Tech Soft Tissue Acellular Dermal Matrix (ADM) Product Portfolio

6.13.5 Yantai Zhenghai Bio-Tech Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Soft Tissue Acellular Dermal Matrix (ADM) Industry Chain Analysis

7.2 Soft Tissue Acellular Dermal Matrix (ADM) Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Soft Tissue Acellular Dermal Matrix (ADM) Production Mode & Process

7.4 Soft Tissue Acellular Dermal Matrix (ADM) Sales and Marketing

7.4.1 Soft Tissue Acellular Dermal Matrix (ADM) Sales Channels

7.4.2 Soft Tissue Acellular Dermal Matrix (ADM) Distributors

7.5 Soft Tissue Acellular Dermal Matrix (ADM) Customers

8 Soft Tissue Acellular Dermal Matrix (ADM) Market Dynamics

8.1 Soft Tissue Acellular Dermal Matrix (ADM) Industry Trends

8.2 Soft Tissue Acellular Dermal Matrix (ADM) Market Drivers

8.3 Soft Tissue Acellular Dermal Matrix (ADM) Market Challenges

8.4 Soft Tissue Acellular Dermal Matrix (ADM) Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Soft Tissue Acellular Dermal Matrix (ADM) Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Soft Tissue Acellular Dermal Matrix (ADM) Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Soft Tissue Acellular Dermal Matrix (ADM) Market Competitive Situation by Manufacturers in 2023

Table 4. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs) of Key Manufacturers (2019-2024)

Table 5. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Soft Tissue Acellular Dermal Matrix (ADM) Average Price (US$/Pc) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Soft Tissue Acellular Dermal Matrix (ADM), Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Soft Tissue Acellular Dermal Matrix (ADM), Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Soft Tissue Acellular Dermal Matrix (ADM), Product Type & Application

Table 12. Global Key Manufacturers of Soft Tissue Acellular Dermal Matrix (ADM), Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Soft Tissue Acellular Dermal Matrix (ADM) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Tissue Acellular Dermal Matrix (ADM) as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Soft Tissue Acellular Dermal Matrix (ADM) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Region (2019-2024) & (K Pcs)

Table 18. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Region (2019-2024)

Table 19. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales by Region (2025-2030) & (K Pcs)

Table 20. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Region (2025-2030)

Table 21. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Region (2019-2024)

Table 23. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Region (2025-2030)

Table 25. North America Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Soft Tissue Acellular Dermal Matrix (ADM) Sales by Country (2019-2024) & (K Pcs)

Table 27. North America Soft Tissue Acellular Dermal Matrix (ADM) Sales by Country (2025-2030) & (K Pcs)

Table 28. North America Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Soft Tissue Acellular Dermal Matrix (ADM) Sales by Country (2019-2024) & (K Pcs)

Table 32. Europe Soft Tissue Acellular Dermal Matrix (ADM) Sales by Country (2025-2030) & (K Pcs)

Table 33. Europe Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Soft Tissue Acellular Dermal Matrix (ADM) Sales by Region (2019-2024) & (K Pcs)

Table 37. Asia Pacific Soft Tissue Acellular Dermal Matrix (ADM) Sales by Region (2025-2030) & (K Pcs)

Table 38. Asia Pacific Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Soft Tissue Acellular Dermal Matrix (ADM) Sales by Country (2019-2024) & (K Pcs)

Table 42. Latin America Soft Tissue Acellular Dermal Matrix (ADM) Sales by Country (2025-2030) & (K Pcs)

Table 43. Latin America Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Soft Tissue Acellular Dermal Matrix (ADM) Sales by Country (2019-2024) & (K Pcs)

Table 47. Middle East and Africa Soft Tissue Acellular Dermal Matrix (ADM) Sales by Country (2025-2030) & (K Pcs)

Table 48. Middle East and Africa Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Soft Tissue Acellular Dermal Matrix (ADM) Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs) by Type (2019-2024)

Table 51. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs) by Type (2025-2030)

Table 52. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Type (2019-2024)

Table 53. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Type (2025-2030)

Table 54. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Type (2019-2024)

Table 57. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Type (2025-2030)

Table 58. Global Soft Tissue Acellular Dermal Matrix (ADM) Price (US$/Pc) by Type (2019-2024)

Table 59. Global Soft Tissue Acellular Dermal Matrix (ADM) Price (US$/Pc) by Type (2025-2030)

Table 60. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs) by Application (2019-2024)

Table 61. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs) by Application (2025-2030)

Table 62. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Application (2019-2024)

Table 63. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Application (2025-2030)

Table 64. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Application (2019-2024)

Table 67. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Application (2025-2030)

Table 68. Global Soft Tissue Acellular Dermal Matrix (ADM) Price (US$/Pc) by Application (2019-2024)

Table 69. Global Soft Tissue Acellular Dermal Matrix (ADM) Price (US$/Pc) by Application (2025-2030)

Table 70. Zimmer Biomet Company Information

Table 71. Zimmer Biomet Description and Business Overview

Table 72. Zimmer Biomet Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)

Table 73. Zimmer Biomet Soft Tissue Acellular Dermal Matrix (ADM) Product

Table 74. Zimmer Biomet Recent Developments/Updates

Table 75. Allergan Company Information

Table 76. Allergan Description and Business Overview

Table 77. Allergan Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)

Table 78. Allergan Soft Tissue Acellular Dermal Matrix (ADM) Product

Table 79. Allergan Recent Developments/Updates

Table 80. Stryker Company Information

Table 81. Stryker Description and Business Overview

Table 82. Stryker Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)

Table 83. Stryker Soft Tissue Acellular Dermal Matrix (ADM) Product

Table 84. Stryker Recent Developments/Updates

Table 85. MTF Biologics Company Information

Table 86. MTF Biologics Description and Business Overview

Table 87. MTF Biologics Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)

Table 88. MTF Biologics Soft Tissue Acellular Dermal Matrix (ADM) Product

Table 89. MTF Biologics Recent Developments/Updates

Table 90. LifeNet Health Company Information

Table 91. LifeNet Health Description and Business Overview

Table 92. LifeNet Health Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)

Table 93. LifeNet Health Soft Tissue Acellular Dermal Matrix (ADM) Product

Table 94. LifeNet Health Recent Developments/Updates

Table 95. Integra LifeSciences Company Information

Table 96. Integra LifeSciences Description and Business Overview

Table 97. Integra LifeSciences Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)

Table 98. Integra LifeSciences Soft Tissue Acellular Dermal Matrix (ADM) Product

Table 99. Integra LifeSciences Recent Developments/Updates

Table 100. Medtronic Company Information

Table 101. Medtronic Description and Business Overview

Table 102. Medtronic Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)

Table 103. Medtronic Soft Tissue Acellular Dermal Matrix (ADM) Product

Table 104. Medtronic Recent Developments/Updates

Table 105. Arthrex Company Information

Table 106. Arthrex Description and Business Overview

Table 107. Arthrex Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)

Table 108. Arthrex Soft Tissue Acellular Dermal Matrix (ADM) Product

Table 109. Arthrex Recent Developments/Updates

Table 110. Straumann Company Information

Table 111. Straumann Description and Business Overview

Table 112. Straumann Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)

Table 113. Straumann Soft Tissue Acellular Dermal Matrix (ADM) Product

Table 114. Straumann Recent Developments/Updates

Table 115. Wright Medical Group Company Information

Table 116. Wright Medical Group Description and Business Overview

Table 117. Wright Medical Group Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)

Table 118. Wright Medical Group Soft Tissue Acellular Dermal Matrix (ADM) Product

Table 119. Wright Medical Group Recent Developments/Updates

Table 120. Hans Biomed Company Information

Table 121. Hans Biomed Description and Business Overview

Table 122. Hans Biomed Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)

Table 123. Hans Biomed Soft Tissue Acellular Dermal Matrix (ADM) Product

Table 124. Hans Biomed Recent Developments/Updates

Table 125. Xtant Medical Company Information

Table 126. Xtant Medical Description and Business Overview

Table 127. Xtant Medical Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)

Table 128. Xtant Medical Soft Tissue Acellular Dermal Matrix (ADM) Product

Table 129. Xtant Medical Recent Developments/Updates

Table 130. Yantai Zhenghai Bio-Tech Company Information

Table 131. Yantai Zhenghai Bio-Tech Description and Business Overview

Table 132. Yantai Zhenghai Bio-Tech Soft Tissue Acellular Dermal Matrix (ADM) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2019-2024)

Table 133. Yantai Zhenghai Bio-Tech Soft Tissue Acellular Dermal Matrix (ADM) Product

Table 134. Yantai Zhenghai Bio-Tech Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Soft Tissue Acellular Dermal Matrix (ADM) Distributors List

Table 138. Soft Tissue Acellular Dermal Matrix (ADM) Customers List

Table 139. Soft Tissue Acellular Dermal Matrix (ADM) Market Trends

Table 140. Soft Tissue Acellular Dermal Matrix (ADM) Market Drivers

Table 141. Soft Tissue Acellular Dermal Matrix (ADM) Market Challenges

Table 142. Soft Tissue Acellular Dermal Matrix (ADM) Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of Soft Tissue Acellular Dermal Matrix (ADM)

Figure 2. Global Soft Tissue Acellular Dermal Matrix (ADM) Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Soft Tissue Acellular Dermal Matrix (ADM) Market Share by Type: 2023 & 2030

Figure 4. Human Skin Product Picture

Figure 5. Animal Skin Product Picture

Figure 6. Global Soft Tissue Acellular Dermal Matrix (ADM) Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global Soft Tissue Acellular Dermal Matrix (ADM) Market Share by Application: 2023 & 2030

Figure 8. Plastic Surgery

Figure 9. Gynecology

Figure 10. Others

Figure 11. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Soft Tissue Acellular Dermal Matrix (ADM) Market Size (2019-2030) & (US$ Million)

Figure 13. Global Soft Tissue Acellular Dermal Matrix (ADM) Sales (2019-2030) & (K Pcs)

Figure 14. Global Soft Tissue Acellular Dermal Matrix (ADM) Average Price (US$/Pc) & (2019-2030)

Figure 15. Soft Tissue Acellular Dermal Matrix (ADM) Report Years Considered

Figure 16. Soft Tissue Acellular Dermal Matrix (ADM) Sales Share by Manufacturers in 2023

Figure 17. Global Soft Tissue Acellular Dermal Matrix (ADM) Revenue Share by Manufacturers in 2023

Figure 18. Global 5 and 10 Largest Soft Tissue Acellular Dermal Matrix (ADM) Players: Market Share by Revenue in Soft Tissue Acellular Dermal Matrix (ADM) in 2023

Figure 19. Soft Tissue Acellular Dermal Matrix (ADM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 20. Global Soft Tissue Acellular Dermal Matrix (ADM) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Country (2019-2030)

Figure 22. North America Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Country (2019-2030)

Figure 23. United States Soft Tissue Acellular Dermal Matrix (ADM) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Soft Tissue Acellular Dermal Matrix (ADM) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Country (2019-2030)

Figure 26. Europe Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Country (2019-2030)

Figure 27. Germany Soft Tissue Acellular Dermal Matrix (ADM) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Soft Tissue Acellular Dermal Matrix (ADM) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Soft Tissue Acellular Dermal Matrix (ADM) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Soft Tissue Acellular Dermal Matrix (ADM) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Soft Tissue Acellular Dermal Matrix (ADM) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Region (2019-2030)

Figure 34. China Soft Tissue Acellular Dermal Matrix (ADM) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Soft Tissue Acellular Dermal Matrix (ADM) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Soft Tissue Acellular Dermal Matrix (ADM) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Soft Tissue Acellular Dermal Matrix (ADM) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Soft Tissue Acellular Dermal Matrix (ADM) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Soft Tissue Acellular Dermal Matrix (ADM) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Soft Tissue Acellular Dermal Matrix (ADM) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Country (2019-2030)

Figure 42. Mexico Soft Tissue Acellular Dermal Matrix (ADM) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Brazil Soft Tissue Acellular Dermal Matrix (ADM) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Argentina Soft Tissue Acellular Dermal Matrix (ADM) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Colombia Soft Tissue Acellular Dermal Matrix (ADM) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East and Africa Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Share by Country (2019-2030)

Figure 47. Middle East and Africa Soft Tissue Acellular Dermal Matrix (ADM) Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Soft Tissue Acellular Dermal Matrix (ADM) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Soft Tissue Acellular Dermal Matrix (ADM) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Soft Tissue Acellular Dermal Matrix (ADM) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Soft Tissue Acellular Dermal Matrix (ADM) by Type (2019-2030)

Figure 52. Global Revenue Market Share of Soft Tissue Acellular Dermal Matrix (ADM) by Type (2019-2030)

Figure 53. Global Soft Tissue Acellular Dermal Matrix (ADM) Price (US$/Pc) by Type (2019-2030)

Figure 54. Global Sales Market Share of Soft Tissue Acellular Dermal Matrix (ADM) by Application (2019-2030)

Figure 55. Global Revenue Market Share of Soft Tissue Acellular Dermal Matrix (ADM) by Application (2019-2030)

Figure 56. Global Soft Tissue Acellular Dermal Matrix (ADM) Price (US$/Pc) by Application (2019-2030)

Figure 57. Soft Tissue Acellular Dermal Matrix (ADM) Value Chain

Figure 58. Soft Tissue Acellular Dermal Matrix (ADM) Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Soft Tissue Acellular Dermal Matrix (ADM) in 2024? zhanKai

The global market size of Soft Tissue Acellular Dermal Matrix (ADM) in 2024 was 89.2 Million USD.

Which companies rank high in the global Soft Tissue Acellular Dermal Matrix (ADM) market? shouQi

What is the annual compound growth rate of the global Soft Tissue Acellular Dermal Matrix (ADM) market size from 2024 to 2030? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Soft Tissue Acellular Dermal Matrix (ADM) in 2030? shouQi

Related Reports

Global Soft Tissue Acellular Dermal Matrix (ADM) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Soft Tissue Acellular Dermal Matrix (ADM) market is projected to grow from US$ 91.45 million in 2025 to US$ 111 million by 2032, at a CAGR of 2.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-25
Pages: 151
USD 4900.00
(Single User License)
Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Soft Tissue Acellular Dermal Matrix (ADM) market size was US$ 91.45 million in 2025 and is forecast to reach a readjusted size of US$ 111 million by 2032 with a CAGR of 2.8% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 94
USD 4250.00
(Single User License)
Global Soft Tissue Acellular Dermal Matrix (ADM) Market Research Report 2026
The global Soft Tissue Acellular Dermal Matrix (ADM) market was valued at US$ 91.45 million in 2025 and is anticipated to reach US$ 111 million by 2032, at a CAGR of 2.8% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 120
USD 2900.00
(Single User License)
Soft Tissue Acellular Dermal Matrix (ADM)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Soft Tissue Acellular Dermal Matrix (ADM) was estimated to be worth US$ 91.45 million in 2025 and is projected to reach US$ 111 million, growing at a CAGR of 2.8% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 123
USD 3950.00
(Single User License)
Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Soft Tissue Acellular Dermal Matrix (ADM) market size was US$ 89.2 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 91
USD 4250.00
(Single User License)
Global Soft Tissue Acellular Dermal Matrix (ADM) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Soft Tissue Acellular Dermal Matrix (ADM) market is projected to grow from US$ 89.2 million in 2024 to US$ 108 million by 2031, at a CAGR of 2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 153
USD 4900.00
(Single User License)
Soft Tissue Acellular Dermal Matrix (ADM) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Soft Tissue Acellular Dermal Matrix (ADM) was estimated to be worth US$ 89.2 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 123
USD 3950.00
(Single User License)
Global Soft Tissue Acellular Dermal Matrix (ADM) Market Research Report 2025
The global market for Soft Tissue Acellular Dermal Matrix (ADM) was valued at US$ 89.2 million in the year 2024 and is projected to reach a revised size of US$ 108 million by 2031, growing at a CAGR of 2.8% during the forecast period.
Published Date: 2025-03-10
Pages: 94
USD 2900.00
(Single User License)
Global Soft Tissue Acellular Dermal Matrix (ADM) Market Insights, Forecast to 2030
The global Soft Tissue Acellular Dermal Matrix (ADM) market is projected to grow from US$ 89.2 million in 2024 to US$ 105 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.8% during the forecast period.
Published Date: 2024-11-15
Pages: 150
USD 4900.00
(Single User License)
Global and United States Soft Tissue Acellular Dermal Matrix (ADM) Market Report & Forecast 2024-2030
The global Soft Tissue Acellular Dermal Matrix (ADM) revenue was US$ 76.8 million in 2023 and is forecast to a readjusted size of US$ 105 million by 2030 with a CAGR of 2.8% during the review period (2024-2030).
Published Date: 2024-11-15
Pages: 125
USD 4350.00
(Single User License)

Global Soft Tissue Acellular Dermal Matrix (ADM) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Soft Tissue Acellular Dermal Matrix (ADM) market is projected to grow from US$ 91.45 million in 2025 to US$ 111 million by 2032, at a CAGR of 2.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-25
Pages: 151
USD 4900.00 (Single User License)
Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Soft Tissue Acellular Dermal Matrix (ADM) market size was US$ 91.45 million in 2025 and is forecast to reach a readjusted size of US$ 111 million by 2032 with a CAGR of 2.8% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 94
USD 4250.00 (Single User License)
Global Soft Tissue Acellular Dermal Matrix (ADM) Market Research Report 2026
The global Soft Tissue Acellular Dermal Matrix (ADM) market was valued at US$ 91.45 million in 2025 and is anticipated to reach US$ 111 million by 2032, at a CAGR of 2.8% from 2026 to 2032.
Published: 2026-01-08
Pages: 120
USD 2900.00 (Single User License)
Soft Tissue Acellular Dermal Matrix (ADM)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Soft Tissue Acellular Dermal Matrix (ADM) was estimated to be worth US$ 91.45 million in 2025 and is projected to reach US$ 111 million, growing at a CAGR of 2.8% from 2026 to 2032.
Published: 2026-01-08
Pages: 123
USD 3950.00 (Single User License)
Global Soft Tissue Acellular Dermal Matrix (ADM) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Soft Tissue Acellular Dermal Matrix (ADM) market size was US$ 89.2 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 91
USD 4250.00 (Single User License)
Global Soft Tissue Acellular Dermal Matrix (ADM) Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Soft Tissue Acellular Dermal Matrix (ADM) market is projected to grow from US$ 89.2 million in 2024 to US$ 108 million by 2031, at a CAGR of 2.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 153
USD 4900.00 (Single User License)
Soft Tissue Acellular Dermal Matrix (ADM) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Soft Tissue Acellular Dermal Matrix (ADM) was estimated to be worth US$ 89.2 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 123
USD 3950.00 (Single User License)
Global Soft Tissue Acellular Dermal Matrix (ADM) Market Research Report 2025
The global market for Soft Tissue Acellular Dermal Matrix (ADM) was valued at US$ 89.2 million in the year 2024 and is projected to reach a revised size of US$ 108 million by 2031, growing at a CAGR of 2.8% during the forecast period.
Published: 2025-03-10
Pages: 94
USD 2900.00 (Single User License)
Global Soft Tissue Acellular Dermal Matrix (ADM) Market Insights, Forecast to 2030
The global Soft Tissue Acellular Dermal Matrix (ADM) market is projected to grow from US$ 89.2 million in 2024 to US$ 105 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.8% during the forecast period.
Published: 2024-11-15
Pages: 150
USD 4900.00 (Single User License)
Global and United States Soft Tissue Acellular Dermal Matrix (ADM) Market Report & Forecast 2024-2030
The global Soft Tissue Acellular Dermal Matrix (ADM) revenue was US$ 76.8 million in 2023 and is forecast to a readjusted size of US$ 105 million by 2030 with a CAGR of 2.8% during the review period (2024-2030).
Published: 2024-11-15
Pages: 125
USD 4350.00 (Single User License)